Category: Global Regulation
The 80-125% Rule: Understanding Bioequivalence Confidence Intervals
Clarifies the 80-125% bioequivalence rule, debunking myths about generic drug strength. Explains pharmacokinetic parameters, confidence intervals, and regulatory standards for safe medication.
Predicting Generic Entry: How to Forecast When Your Drug Loses Exclusivity
Learn how to accurately predict generic drug entry using patent data, FDA Orange Book insights, and advanced forecasting models. Understand the impact of litigation, biosimilars, and evergreening strategies on your drug's market exclusivity.
Affirmative Consent Laws vs. Medical Substitution: Clearing Up the Confusion
Affirmative consent laws apply to sexual activity, not medical care. Learn how medical substitution actually works via informed consent and substituted judgment doctrines.
How FDA Monitors Generic Drug Safety After Approval
Discover how the FDA monitors generic drug safety after approval using FAERS, the Sentinel Initiative, and strict manufacturing inspections to ensure patient protection.
Mandatory Substitution Laws Worldwide: A Comparison of Legal Frameworks
Analyze global legal frameworks for mandatory substitution in banking, mental health, and environment. Compare EU vs US approaches, CRPD impacts, and REACH chemical regulations.